The euro hit a two-year low against the dollar last week on fears that a European debt crisis may force Greece to exit the euro zone and that Spain may need to issue more debt to recapitalize its banks.
Komas said Danaher's industrial businesses, such as test and measurement equipment, were one area of weakness in Europe, along with its life sciences business, which relies in part on government research budgets. However, demand for medical diagnostic equipment remains "pretty good" in Europe, he said.
Asked whether the current economic weakness felt like 2008, at the outset of recession, Komas said it did not.
"If you go back to the fall of '08, even the late summer, pre the Lehman bankruptcy, you saw a noticeable delta between orders and shipments," he said. "It was a real sign things are going to turn south. We're not seeing that. We're seeing pockets of weakness."
For Danaher, which has long relied on mergers and acquisitions to fuel growth, weak markets have a silver lining because they reduce asset prices.
"Every dynamic presents an opportunity," Komas said.
Shares of Danaher were up 0.9 percent at $50.80 in early trading.
- Link this
- Share this
- Digg this
- Email
- Reprints
0 comments:
Post a Comment